InvestorsHub Logo
Followers 831
Posts 120032
Boards Moderated 17
Alias Born 09/05/2002

Re: DewDiligence post# 1870

Friday, 05/01/2020 10:02:38 AM

Friday, May 01, 2020 10:02:38 AM

Post# of 3017
ABBV's 2020 HCV-sales guidance lowered to $2.3B (from prior guidance of $2.5B). The new $2.3B figure is consistent with the 1Q20 HCV sales of $564M (#msg-155372271).

On today’s 1Q20 CC, ABBV said about half of the $200K guidance reduction stems from COVID-19 issues.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News